Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-07-02 6:10 pm Purchase | 2024-07-01 | 13G | Lumentum Holdings Inc. LITE | Point72 Asset Management, L.P. | 3,382,398 5.000% | 3,382,398 (New Position) | Filing History |
| 2024-06-24 4:51 pm Purchase | 2024-06-14 | 13G | UroGen Pharma Ltd. URGN | Point72 Asset Management, L.P. | 2,569,826 6.200% | 2,569,826 (New Position) | Filing History |
| 2024-06-24 4:16 pm Purchase | 2024-06-21 | 13G | Sphere Entertainment Co. SPHR | Point72 Asset Management, L.P. | 1,560,170 5.500% | 1,560,170 (New Position) | Filing History |
| 2024-06-14 4:34 pm Purchase | 2024-06-04 | 13G | Olema Pharmaceuticals, Inc. OLMA | Point72 Asset Management, L.P. | 3,225,250 5.700% | 3,225,250 (New Position) | Filing History |
| 2024-06-10 4:29 pm Purchase | 2024-06-07 | 13G | Maravai LifeSciences Holdings, Inc. MRVI | Point72 Asset Management, L.P. | 6,647,015 5.000% | 6,647,015 (New Position) | Filing History |
| 2024-05-21 4:56 pm Purchase | 2024-05-20 | 13G | Rapid7, Inc. RPD | Point72 Asset Management, L.P. | 3,121,415 5.000% | 1,243,804 (+66.24%) | Filing History |
| 2024-05-09 5:29 pm Purchase | 2024-05-02 | 13G | Corvus Pharmaceuticals, Inc. CRVS | Point72 Asset Management, L.P. | 17,050,384 9.900% | 17,050,384 (New Position) | Filing History |
| 2024-04-26 4:15 pm Purchase | 2024-04-25 | 13G | Avid Bioservices, Inc. CDMO | Point72 Asset Management, L.P. | 3,226,006 5.100% | 3,226,006 (New Position) | Filing History |
| 2024-04-05 4:05 pm Purchase | 2024-04-04 | 13G | Sutro Biopharma, Inc. STRO | Point72 Asset Management, L.P. | 5,932,908 7.900% | 5,932,908 (New Position) | Filing History |
| 2024-03-26 4:21 pm Purchase | 2024-03-25 | 13G | Fox Corporation FOXA | Point72 Asset Management, L.P. | 12,046,118 5.000% | 12,046,118 (New Position) | Filing History |
| 2024-03-25 4:33 pm Purchase | 2024-03-21 | 13G | LENZ Therapeutics, Inc. LENZ | Point72 Asset Management, L.P. | 1,882,693 7.400% | 1,882,693 (New Position) | Filing History |
| 2024-03-07 4:15 pm Purchase | 2024-03-06 | 13G | Terns Pharmaceuticals, Inc. TERN | Point72 Asset Management, L.P. | 3,921,226 6.300% | 3,921,226 (New Position) | Filing History |
| 2024-02-29 4:31 pm Purchase | 2024-02-28 | 13G | Pulmonx Corporation LUNG | Point72 Asset Management, L.P. | 1,936,083 5.000% | 389,994 (+25.22%) | Filing History |
| 2024-02-27 4:14 pm Purchase | 2024-02-26 | 13G | Liberty Live Group LLYVA | Point72 Asset Management, L.P. | 1,287,149 5.000% | 1,287,149 (New Position) | Filing History |
| 2024-02-23 4:28 pm Purchase | 2024-02-22 | 13G | Ventyx Biosciences, Inc. VTYX | Point72 Asset Management, L.P. | 3,017,093 5.100% | 3,017,093 (New Position) | Filing History |
| 2024-02-23 4:15 pm Purchase | 2024-02-22 | 13G | Caribou Biosciences, Inc. CRBU | Point72 Asset Management, L.P. | 4,432,602 5.000% | 435,057 (+10.88%) | Filing History |
| 2024-02-21 4:16 pm Purchase | 2024-02-20 | 13G | Agenus Inc. AGEN | Point72 Asset Management, L.P. | 1,413,425 6.800% | 1,413,368 (+2492389.95%) | Filing History |
| 2024-02-14 4:20 pm Purchase | 2023-12-31 | 13G | Abeona Therapeutics Inc. ABEO | Point72 Asset Management, L.P. | 1,649,740 6.400% | 499,092 (+43.37%) | Filing History |
| 2024-02-14 4:19 pm Purchase | 2023-12-31 | 13G | PagSeguro Digital Ltd. PAGS | Point72 Asset Management, L.P. | 10,933,610 5.600% | 231,012 (+2.16%) | Filing History |
| 2024-02-14 4:18 pm Purchase | 2023-12-31 | 13G | Lyra Therapeutics, Inc. LYRA | Point72 Asset Management, L.P. | 60,606 5.800% | 606 (+1.01%) | Filing History |